StockData
Anixa Biosciences Inc logo

Anixa Biosciences Inc (ANIX) stock

ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 9, 2026Score 6/30
$2.67+0.12 (+4.71%)

Close on Nov 17, 2026Market cap $92.82MP/E –Yield –

Anixa Biosciences gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2012 it was 99.6%, against 96.6% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2012Oct 31, 201299.6%+3.0
FY2011Oct 31, 201196.6%+7.9
FY2010Oct 31, 201088.7%–

More Anixa Biosciences figures

See a number that looks wrong?